Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eleonora Vandini

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
European Journal of Pharmacology|July 19, 2014
Melanocortins protect against brain damage and counteract cognitive decline in a transgenic mouse model of moderate Alzheimer׳s diseaseDaniela Giuliani, Maria Galantucci, Laura Neri, et al.
Science Advances|April 16, 2025
In vivo and in situ monitoring of doxorubicin pharmacokinetics with an implantable bioresorbable optical sensorMartina Corsi, Elena Maurina, Salvatore Surdo, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 17, 2026
Thermally Degradable Biocompatible Hydrogel as Transient Encapsulation Coating for Implantable SensorsFrancesca Persano, Eleonora Vandini, Eleonora Daini, et al.
Brain, Behavior, and Immunity|November 15, 2023
PCSK9 ablation attenuates Aβ pathology, neuroinflammation and cognitive dysfunctions in 5XFAD miceAntonietta Vilella, Martina Bodria, Bianca Papotti, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 28, 2026
Current Collector Engineering for New Efficient Bioresorbable Sodium-Ion BatteriesBincy Lathakumary Vijayan, Eleonora Vandini, Vedi Kuyil Azhagan Muniraj, et al.
Pharmaceuticals (Basel, Switzerland)|December 28, 2021
Identification of a Thyroid Hormone Derivative as a Pleiotropic Agent for the Treatment of Alzheimer's DiseaseMassimiliano Runfola, Michele Perni, Xiaoting Yang, et al.
Biochemical Pharmacology|November 30, 2023
Melanocortin receptor 4 as a new target in melanoma therapy: Anticancer activity of the inhibitor ML00253764 alone and in association with B-raf inhibitor vemurafenibPaola Orlandi, Marta Banchi, Francesca Vaglini, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
European Journal of Pharmacology|July 19, 2014
Melanocortins protect against brain damage and counteract cognitive decline in a transgenic mouse model of moderate Alzheimer׳s diseaseDaniela Giuliani, Maria Galantucci, Laura Neri, et al.
Science Advances|April 16, 2025
In vivo and in situ monitoring of doxorubicin pharmacokinetics with an implantable bioresorbable optical sensorMartina Corsi, Elena Maurina, Salvatore Surdo, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 17, 2026
Thermally Degradable Biocompatible Hydrogel as Transient Encapsulation Coating for Implantable SensorsFrancesca Persano, Eleonora Vandini, Eleonora Daini, et al.
Brain, Behavior, and Immunity|November 15, 2023
PCSK9 ablation attenuates Aβ pathology, neuroinflammation and cognitive dysfunctions in 5XFAD miceAntonietta Vilella, Martina Bodria, Bianca Papotti, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 28, 2026
Current Collector Engineering for New Efficient Bioresorbable Sodium-Ion BatteriesBincy Lathakumary Vijayan, Eleonora Vandini, Vedi Kuyil Azhagan Muniraj, et al.
Pharmaceuticals (Basel, Switzerland)|December 28, 2021
Identification of a Thyroid Hormone Derivative as a Pleiotropic Agent for the Treatment of Alzheimer's DiseaseMassimiliano Runfola, Michele Perni, Xiaoting Yang, et al.
Biochemical Pharmacology|November 30, 2023
Melanocortin receptor 4 as a new target in melanoma therapy: Anticancer activity of the inhibitor ML00253764 alone and in association with B-raf inhibitor vemurafenibPaola Orlandi, Marta Banchi, Francesca Vaglini, et al.
Pageof 2